This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Resistentia Pharmaceuticals Ab. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: Lars T Hellman: Innovator in Immunogenic Polypeptides
Introduction
Lars T Hellman is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the field of immunology, particularly in the development of innovative methods for treating and preventing diseases related to IgE antibodies. With a total of 3 patents, his work has the potential to impact the medical community significantly.
Latest Patents
One of Lars T Hellman's latest patents focuses on immunogenic polypeptides for inducing anti-self IgE responses. This invention relates to methods and materials involved in the treatment and prevention of various diseases, including infections and IgE-related conditions. The methods described can be utilized to vaccinate mammals against specific self or non-self antigens, aiming to reduce the effects of IgE antibodies by decreasing the total and receptor-bound IgE levels in the mammal. Additionally, this patent includes the development of vaccine conjugates, immunogenic polypeptides, and nucleic acid molecules that encode these polypeptides, along with methods for their production.
Another significant patent addresses methods and materials for treating inflammatory conditions. This invention provides polypeptides, isolated nucleic acids, and host cells that can induce an antibody response against antigens such as C5. The methods aim to mitigate the effects of C5 within mammals by reducing the total and receptor-bound C5 levels.
Career Highlights
Lars T Hellman is currently associated with Resistentia Pharmaceuticals AB, where he continues to advance his research and innovations in immunology. His work is characterized by a strong focus on developing therapeutic solutions that can improve patient outcomes in various medical conditions.
Collaborations
Lars collaborates with Rikard Holmdahl, a fellow researcher, to further enhance the impact of their work in the field of immunology.
Conclusion
Lars T Hellman's contributions to immunogenic polypeptides and methods for treating inflammatory conditions highlight his role as an influential inventor in the medical field. His innovative approaches have the potential to lead to significant advancements in the treatment of IgE-related diseases and inflammatory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile